Tandem Diabetes Care, Inc. TNDM R2K
Healthcare · Medical Devices · United States
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
READ MORE ›$17.20
-13.22% 1Y
Market & Price
Market Cap
$1.18B
Current Price
$17.20
High / Low (52W)
$28.26 / $10.12
Beta
1.64
Valuation
Stock P/E
-
Industry PE
23.65
Forward P/E
292.82
PEG Ratio
-
Book Value
$2.27
Price to Book
7.57
P/S
1.15
EV/EBITDA
-31.09
Dividend Yield
-
Profitability & Returns
ROCE
-30.42%
ROE
-65.73%
ROA
-3.68%
Profit Margin
-9.20%
Op Margin
-7.05%
EPS (Latest Qtr)
$-0.30
EPS (TTM)
$-1.37
Balance Sheet & Liquidity
Debt/Equity
5.55
Quick Ratio
2.87
Current Ratio
3.58
Debt
$734.73M
Total Assets
$881.11M
Current Assets
$618.14M
Working Capital
$375.42M
Ownership
Promoter Holding
0.97%
Chg in Prom Hold
-
FII / Inst Holding
117.88%
Chg in FII Hold
-0.02%
Financial Snapshot
Enterprise Value
$1.34B
Total Revenue (TTM)
$1.03B
EBITDA
$-43.20M
Free Cash Flow
$-20.26M
Operating Cash Flow
$19.61M
Shares Outstanding
68.53M
Gross Margin
54.93%
Payout Ratio
0.00%
Growth (CAGR)
Revenue 5Y
8.19%
Profit 5Y
-38.80%
Revenue (YoY)
5.50%
Earnings (YoY)
-
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Earnings shrank at -38.8% CAGR over 5 years.
- Trading 39.1% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Healthcare).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | TNDM Tandem Diabetes Care, Inc. R2K | 17.20 | - | $1.18B | - | -30.42% | -65.73% | 8.19% | -38.80% |
| 2 | LLY Eli Lilly and Company SPX | 1,105.00 | 39.21 | $985.37B | 0.63% | 38.44% | 107.46% | 31.69% | 48.96% |
| 3 | JNJ Johnson & Johnson SPX | 225.33 | 26.11 | $542.42B | 2.38% | 23.13% | 26.42% | 5.60% | 14.32% |
| 4 | UNH UnitedHealth Group Incorporated SPX | 380.31 | 28.66 | $345.38B | 2.32% | 9.60% | 12.18% | 11.35% | -15.69% |
| 5 | MRK Merck & Co., Inc. SPX | 118.72 | 33.44 | $293.22B | 2.86% | 20.66% | 18.94% | 3.12% | 7.93% |
| 6 | TMO Thermo Fisher Scientific Inc. SPX | 492.51 | 27.11 | $183.03B | 0.38% | 9.17% | 13.52% | -0.27% | -1.19% |
| 7 | AMGN Amgen Inc. NDXSPX | 336.79 | 23.42 | $181.77B | 2.99% | 18.02% | 101.32% | 11.77% | 5.58% |
| 8 | GILD Gilead Sciences, Inc. NDXSPX | 134.43 | 18.29 | $166.90B | 2.44% | 22.92% | 43.36% | 2.57% | 22.83% |
| 9 | ISRG Intuitive Surgical, Inc. NDXSPXAI | 424.64 | 51.53 | $150.39B | - | 15.96% | 17.23% | 17.39% | 29.26% |
Ad space
Quarterly Results
Figures in USD.
| Metric | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | 18.98M | 21.33M | 27.00M | 40.29M | 27.28M | 34.13M | 46.26M | 76.20M | 66.00M | 93.25M | 94.66M | 108.40M | 97.93M | 109.24M | 123.60M | 168.06M | 141.04M | 172.14M | 179.63M | 210.00M | 175.91M | 200.26M | 204.55M | 220.50M | 169.38M | 195.92M | 185.62M | 196.80M | 191.67M | 221.91M | 243.97M | - | 234.42M | 240.68M | 249.25M | 290.38M | 247.22M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 116.02M | 114.82M | 114.96M | 122.92M | 110.43M |
| Gross Profit | 8.18M | -1.58M | 10.06M | 6.75M | 8.00M | 11.87M | 17.47M | 11.40M | 15.09M | 21.80M | 41.53M | 33.35M | 49.90M | 50.68M | 60.27M | 50.26M | 54.39M | 65.31M | 90.56M | 73.29M | 92.45M | 96.75M | 113.73M | 91.09M | 101.95M | 104.42M | 115.52M | 82.91M | 101.73M | 89.75M | 93.30M | 94.67M | 112.79M | 124.65M | - | 118.41M | 125.86M | 134.29M | 167.46M | 136.79M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 239.28M | 157.71M | 157.16M | 159.17M | 154.22M |
| Operating Income | -17.05M | -28.41M | -13.35M | -21.23M | -18.97M | -13.17M | -9.58M | -15.48M | -14.00M | -15.71M | 560.00K | -11.00M | -1.86M | -6.00M | 2.14M | -13.57M | -12.04M | -1.01M | 18.66M | -3.24M | 5.43M | 7.72M | 12.74M | -15.34M | -12.24M | -47.49M | -17.78M | -127.82M | -38.81M | -31.55M | -35.06M | -41.68M | -30.77M | -26.09M | - | -120.88M | -31.86M | -22.86M | 8.29M | -17.43M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -116.42M | -50.82M | -18.59M | 9.39M | -13.74M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.36M | 2.54M | 2.06M | 215.00K | 1.63M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -122.09M | -57.72M | -25.14M | 4.68M | -19.88M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8.47M | -5.32M | -3.98M | 5.27M | 516.00K |
| Net Income | -18.33M | -29.82M | -14.82M | -23.79M | -21.80M | -16.03M | -11.41M | -32.69M | -59.36M | -34.24M | 3.69M | -22.99M | -1.51M | -2.90M | 2.65M | -14.87M | -27.11M | -9.41M | 17.00M | -5.04M | 4.01M | 5.79M | 10.81M | -14.71M | -15.06M | -48.97M | -15.85M | -123.87M | -35.77M | -32.96M | -30.00M | -42.72M | -30.81M | -23.25M | - | -130.56M | -52.40M | -21.16M | -589.00K | -20.39M |
| Diluted EPS | - | - | - | - | - | - | - | -1.82 | -1.17 | -0.62 | 0.02 | -0.40 | -0.03 | -0.09 | 0.04 | -0.25 | -0.45 | -0.15 | 0.22 | -0.08 | 0.06 | 0.09 | 0.16 | -0.23 | -0.24 | -0.76 | -0.25 | -1.92 | -0.55 | -0.51 | -0.46 | -0.65 | -0.47 | -0.35 | - | -1.97 | -0.78 | -0.31 | -0.01 | -0.30 |
| R&D Expense | 4.14M | 6.15M | - | 5.13M | 4.87M | 4.91M | - | 5.97M | 6.46M | 8.00M | - | 9.39M | 11.20M | 12.04M | - | 14.12M | 15.99M | 16.09M | - | 17.96M | 20.50M | 24.10M | - | 33.16M | 33.57M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 84.25M | 107.60M | 183.87M | 362.31M | 498.83M | - | 801.22M | 747.72M | 940.20M | 1.01B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | 388.23M | 380.03M | 450.63M | 468.72M |
| Gross Profit | -1.35M | 6.17M | 15.25M | 26.58M | 23.59M | 44.09M | 89.82M | 194.21M | 260.52M | - | 412.99M | 367.69M | 489.57M | 546.01M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | 505.83M | 600.92M | 588.70M | 713.32M |
| Operating Income | -33.05M | -49.43M | -75.66M | -69.00M | -78.05M | -62.94M | -44.63M | -16.72M | -7.96M | - | -92.85M | -233.23M | -99.13M | -167.31M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | -74.21M | -196.46M | -69.75M | -176.56M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | 4.31M | 8.08M | 5.51M | 6.05M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | -92.85M | -220.25M | -91.87M | -200.27M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | 1.74M | 2.36M | 4.16M | 4.44M |
| Net Income | -33.02M | -63.14M | -79.52M | -72.42M | -83.45M | -73.03M | -122.61M | -24.75M | -34.38M | - | -94.59M | -222.61M | -96.03M | -204.71M |
| Diluted EPS | - | - | - | - | - | - | - | -0.42 | -0.56 | - | -1.47 | -3.43 | -1.47 | -3.04 |
| R&D Expense | 9.01M | 11.08M | 15.79M | 16.96M | 18.81M | 20.66M | 29.23M | 45.20M | 63.57M | 92.05M | - | - | - | - |
Compounded Sales Growth
| 5 Years: | 8.19% |
| 1 Year: | 5.50% |
Compounded Profit Growth
| 5 Years: | -38.80% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -13.22% |
| 6 Months: | -21.25% |
| 3 Months: | -32.02% |
| 1 Month: | -5.29% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 162.22M | 106.46M | 124.72M | 112.39M | 95.35M | 206.29M | 326.11M | 716.41M | - | 1.05B | 952.66M | 967.66M | 881.11M |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | 849.98M | 747.99M | 724.49M | 618.14M |
| Cash & Equivalents | 8.66M | 17.16M | 124.39M | 31.18M | 43.09M | 44.68M | 13.70M | 41.83M | 51.17M | 94.61M | - | 172.52M | 58.87M | 69.23M | 90.63M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | 111.12M | 157.94M | 149.61M | 128.77M |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | 114.72M | 105.56M | 114.58M | 165.49M |
| Total Liabilities | - | - | 46.68M | 51.89M | 61.26M | 118.32M | 124.49M | 75.02M | 131.13M | 350.11M | - | 612.84M | 639.03M | 704.56M | 725.94M |
| Current Liabilities | - | - | 14.60M | 18.09M | 26.52M | 31.48M | 36.09M | 66.29M | 99.40M | 103.85M | - | 165.29M | 195.26M | 247.05M | 242.72M |
| Long Term Debt | - | - | - | 30.00M | 30.15M | 81.08M | 82.74M | - | - | - | - | 283.23M | 285.04M | 308.27M | 310.04M |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | 419.88M | 415.67M | 473.56M | 444.48M |
| Total Equity | -71.30M | -106.05M | 115.54M | 54.57M | 63.47M | -5.93M | -29.15M | 131.28M | 194.98M | 366.31M | - | 439.95M | 313.63M | 263.10M | 155.17M |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | 64.51M | 65.55M | 66.26M | 68.29M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | -61.17M | -66.14M | -8.32M | 41.91M | 24.67M | - | 50.46M | -31.81M | 24.23M | -9.72M |
| Investing Cash Flow | - | - | - | - | 10.45M | 2.78M | -90.74M | -56.95M | -296.06M | - | 33.17M | -85.74M | -23.48M | 72.88M |
| Financing Cash Flow | - | - | - | - | 52.31M | 40.38M | 117.18M | 24.21M | 314.44M | - | 16.88M | 4.11M | 8.37M | -43.37M |
| Capital Expenditure | -4.53M | -4.01M | -4.41M | -5.76M | -8.93M | -5.72M | -2.99M | -19.54M | -27.41M | - | -34.10M | -96.30M | -19.23M | -98.54M |
| Free Cash Flow | - | - | - | - | -70.10M | -71.85M | -11.30M | 22.36M | -2.74M | - | 16.37M | -128.11M | 4.99M | -108.26M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - | 100.51M | -113.44M | 9.11M | 19.79M |
| Share Buybacks | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 30.00M | 0 |
Ratios (Annual)
Figures in %.
| Metric | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | 28.0% | 41.0% | 48.9% | 53.6% | 52.2% | - | 51.5% | 49.2% | 52.1% | 53.8% |
| Operating Margin % | - | - | - | - | -92.6% | -58.5% | -24.3% | -4.6% | -1.6% | - | -11.6% | -31.2% | -10.5% | -16.5% |
| Net Margin % | - | - | - | - | -99.0% | -67.9% | -66.7% | -6.8% | -6.9% | - | -11.8% | -29.8% | -10.2% | -20.2% |
| ROE % | 31.1% | -54.6% | -145.7% | -114.1% | 1,407.9% | 250.6% | -93.4% | -12.7% | -9.4% | - | -21.5% | -71.0% | -36.5% | -131.9% |
| ROCE % | - | -33.5% | -85.6% | -70.3% | -96.5% | -106.2% | -31.9% | -7.4% | -1.3% | - | -10.5% | -30.8% | -13.8% | -26.2% |
Shareholding Pattern
Insiders
0.97%
Institutions
117.88%
Public Float
119.03%
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 15.60% | 10.69M | $183.88M |
| 2 | Sessa Capital IM, L.P. | 6.90% | 4.73M | $81.37M |
| 3 | Vanguard Portfolio Management LLC | 5.83% | 3.99M | $68.69M |
| 4 | ArrowMark Colorado Holdings LLC | 4.53% | 3.10M | $53.38M |
| 5 | Vanguard Capital Management LLC | 4.43% | 3.04M | $52.27M |
| 6 | GW&K Investment Management, LLC | 3.92% | 2.69M | $46.25M |
| 7 | State Street Corporation | 3.88% | 2.66M | $45.79M |
| 8 | Driehaus Capital Management, LLC | 3.36% | 2.30M | $39.64M |
| 9 | Goldman Sachs Group Inc | 3.24% | 2.22M | $38.17M |
| 10 | Citadel Advisors Llc | 3.20% | 2.19M | $37.71M |
Analyst View
Loading analyst coverage…
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for TNDM
No recent headlines available.